BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9193357)

  • 1. Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients.
    Bastion Y; Sebban C; Berger F; Felman P; Salles G; Dumontet C; Bryon PA; Coiffier B
    J Clin Oncol; 1997 Apr; 15(4):1587-94. PubMed ID: 9193357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follicular lymphoma in early stages: high risk of relapse and usefulness of the Follicular Lymphoma International Prognostic Index to predict the outcome of patients.
    Plancarte F; López-Guillermo A; Arenillas L; Montoto S; Giné E; Muntañola A; Ferrer A; Villamor N; Bosch F; Colomo L; Balaguer O; Campo E; Montserrat E
    Eur J Haematol; 2006 Jan; 76(1):58-63. PubMed ID: 16343272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population-based analysis of incidence and outcome of transformed non-Hodgkin's lymphoma.
    Al-Tourah AJ; Gill KK; Chhanabhai M; Hoskins PJ; Klasa RJ; Savage KJ; Sehn LH; Shenkier TN; Gascoyne RD; Connors JM
    J Clin Oncol; 2008 Nov; 26(32):5165-9. PubMed ID: 18838711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Follicular Lymphoma International Prognostic Index (FLIPI) and the histological subtype are the most important factors to predict histological transformation in follicular lymphoma.
    Giné E; Montoto S; Bosch F; Arenillas L; Mercadal S; Villamor N; Martínez A; Colomo L; Campo E; Montserrat E; López-Guillermo A
    Ann Oncol; 2006 Oct; 17(10):1539-45. PubMed ID: 16940035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term survival after histologic transformation of low-grade follicular lymphoma.
    Yuen AR; Kamel OW; Halpern J; Horning SJ
    J Clin Oncol; 1995 Jul; 13(7):1726-33. PubMed ID: 7602362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follicular large-cell lymphoma treated with intensive chemotherapy: an analysis of 89 cases included in the LNH87 trial and comparison with the outcome of diffuse large B-cell lymphoma. Groupe d'Etude des Lymphomes de l'Adulte.
    Wendum D; Sebban C; Gaulard P; Coiffier B; Tilly H; Cazals D; Boehn A; Casasnovas RO; Bouabdallah R; Jaubert J; Ferrant A; Diebold J; de Mascarel A; Gisselbrecht C
    J Clin Oncol; 1997 Apr; 15(4):1654-63. PubMed ID: 9193366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term event-free survivors after high-dose therapy and autologous stem-cell transplantation for low-grade follicular lymphoma.
    Andreadis C; Schuster SJ; Chong EA; Svoboda J; Luger SM; Porter DL; Tsai DE; Nasta SD; Elstrom RL; Goldstein SC; Downs LH; Mangan PA; Cunningham KA; Hummel KA; Gimotty PA; Siegel DL; Glatstein E; Stadtmauer EA
    Bone Marrow Transplant; 2005 Dec; 36(11):955-61. PubMed ID: 16205727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma.
    Montoto S; Davies AJ; Matthews J; Calaminici M; Norton AJ; Amess J; Vinnicombe S; Waters R; Rohatiner AZ; Lister TA
    J Clin Oncol; 2007 Jun; 25(17):2426-33. PubMed ID: 17485708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum soluble interleukin-2 receptor level at diagnosis predicts transformation in patients with follicular lymphoma.
    Umino K; Fujiwara SI; Ito S; Mashima K; Minakata D; Nakano H; Yamasaki R; Kawasaki Y; Sugimoto M; Ashizawa M; Hatano K; Okazuka K; Sato K; Oh I; Ohmine K; Suzuki T; Muroi K; Kanda Y
    Leuk Lymphoma; 2017 Feb; 58(2):316-323. PubMed ID: 27267694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project.
    Federico M; Bellei M; Marcheselli L; Luminari S; Lopez-Guillermo A; Vitolo U; Pro B; Pileri S; Pulsoni A; Soubeyran P; Cortelazzo S; Martinelli G; Martelli M; Rigacci L; Arcaini L; Di Raimondo F; Merli F; Sabattini E; McLaughlin P; Solal-Céligny P
    J Clin Oncol; 2009 Sep; 27(27):4555-62. PubMed ID: 19652063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma.
    Glas AM; Knoops L; Delahaye L; Kersten MJ; Kibbelaar RE; Wessels LA; van Laar R; van Krieken JH; Baars JW; Raemaekers J; Kluin PM; van't Veer LJ; de Jong D
    J Clin Oncol; 2007 Feb; 25(4):390-8. PubMed ID: 17200149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of Follicular Lymphoma International Prognostic Index (FLIPI) in patients with follicular lymphoma at first progression.
    Montoto S; López-Guillermo A; Altés A; Perea G; Ferrer A; Camós M; Villela L; Bosch F; Esteve J; Cervantes F; Bladé J; Nomdedeu B; Campo E; Sierra J; Montserrat E
    Ann Oncol; 2004 Oct; 15(10):1484-9. PubMed ID: 15367408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary refractory follicular lymphoma: a poor outcome entity with high risk of transformation to aggressive B cell lymphoma.
    Alonso-Álvarez S; Manni M; Montoto S; Sarkozy C; Morschhauser F; Wondergem MJ; Guarini A; Magnano L; Alcoceba M; Chamuleau M; Galimberti S; Gomes da Silva M; Holte H; Zucca E; Lockmer S; Aurer I; Marcheselli L; Stepanishyna Y; Caballero Barrigón MD; Salles G; Federico M
    Eur J Cancer; 2021 Nov; 157():132-139. PubMed ID: 34508995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follicular large-cell lymphoma: intermediate or low grade?
    Bartlett NL; Rizeq M; Dorfman RF; Halpern J; Horning SJ
    J Clin Oncol; 1994 Jul; 12(7):1349-57. PubMed ID: 8021725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors in follicular lymphoma.
    Relander T; Johnson NA; Farinha P; Connors JM; Sehn LH; Gascoyne RD
    J Clin Oncol; 2010 Jun; 28(17):2902-13. PubMed ID: 20385990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET/CT Assessment of Follicular Lymphoma and High Grade B Cell Lymphoma - Good Correlation with Clinical and Histological Features at Diagnosis.
    Novelli S; Briones J; Flotats A; Sierra J
    Adv Clin Exp Med; 2015; 24(2):325-30. PubMed ID: 25931367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Histologic Transformation.
    Casulo C
    Hematol Oncol Clin North Am; 2020 Aug; 34(4):785-794. PubMed ID: 32586581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transformation Scoring System (TSS): A new assessment index for clinical transformation of follicular lymphoma.
    Shichijo T; Maruyama D; Yamauchi N; Maeshima AM; Sugano M; Yuda S; Tajima K; Kurihara H; Shimada K; Suzuki T; Toyoda K; Makita S; Fukuhara S; Munakata W; Suzuki T; Kobayashi Y; Taniguchi H; Minami Y; Izutsu K; Tobinai K
    Cancer Med; 2020 Dec; 9(23):8864-8874. PubMed ID: 33022120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does follicularity in large cell lymphoma predict outcome after autologous stem cell transplantation?
    Krishnan A; Nademanee A; Fung H; Angelopoulou M; Molina A; Gaal K; Dagis A; Palmer J; Alvarnas J; Slovak M; Kogut N; Popplewell L; Rodriguez R; Schriber J; Wang S; Forman SJ
    Biol Blood Marrow Transplant; 2006 Jun; 12(6):641-7. PubMed ID: 16737937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis.
    Federico M; Caballero Barrigón MD; Marcheselli L; Tarantino V; Manni M; Sarkozy C; Alonso-Álvarez S; Wondergem M; Cartron G; Lopez-Guillermo A; Issa D; Morschhauser F; Alcoceba M; Kimby E; Rusconi C; Chamuleau M; Holte H; Lockmer S; Montoto S; Gomes da Silva M; Aurer I; Zucca E; Paszkiewicz-Kozik E; Minoia C; Skrypets T; Blaker YN; Salles G; Coiffier B;
    Lancet Haematol; 2018 Aug; 5(8):e359-e367. PubMed ID: 30078408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.